Guy L. Reed
26Patents
5h-index
7Co-inventors
62Inventor score
Filing activity: Sep 10, 1992 → Nov 14, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5582862A | Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5854049A | Plasmin-resistant streptokinase | Chemistry; Metallurgy | 10 | Expired |
| US5372812A | Composition and method for acceleration of clot lysis | Human Necessities | 8 | Expired |
| USD397885S | Display case for photographs and cards resembling a baseball bat | General | 6 | Expired |
| US5939540A | Platelet secretory transport protein | Chemistry; Metallurgy | 6 | Expired |
| US6534035B1 | Methods of inhibiting clot formation | Human Necessities | 5 | Expired |
| US5446132A | Thrombin-activated platelet protein-2 (TAPP-2) | Human Necessities | 5 | Expired |
| US5773228A | Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto | Chemistry; Metallurgy | 5 | Expired |
| US6114506A | Composition and method for enhancing fibrinolysis | Chemistry; Metallurgy | 4 | Expired |
| US5332665A | Species specific, high affinity monoclonal antibodies | Chemistry; Metallurgy | 4 | Expired |
| US5620688A | Methods of inhibiting the activation of Factor XIII | Human Necessities | 4 | Expired |
| US5470957A | Immunoinhibitors of factor XIII | Human Necessities | 3 | Expired |
| US6210667A | Bacterial fibrin-dependent plasminogen activator | Chemistry; Metallurgy | 2 | Expired |
| US9150903B2 | Method of increasing plasmin activity through antiplasmin conversion | Human Necessities | 2 | Active |
| US6280730A | Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6576431B2 | Antibodies that bind to &agr;2-antiplasmin crosslinked to fibrin which do not inhibit plasma &agr;2-antiplasmin | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9834614B2 | Method of increasing plasmin activity through antiplasmin conversion | Human Necessities | 1 | Active |
| US10160813B2 | Tissue plasminogen activator antibodies and methods of use | Physics | 1 | Active |
| US5831031A | Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11236176B2 | Serpinf2-binding molecules and method of use thereof | Human Necessities | 0 | Active |
| US11066482B2 | Specific plasmin inactivation by anticatalytic antibody | Chemistry; Metallurgy | 0 | Active |
| US10676539B2 | Tissue plasminogen activator antibodies and methods of use | Physics | 0 | Active |
| US6750323B1 | Platelet activation protein | Human Necessities | 0 | Expired |
| US11345758B2 | Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injury | Chemistry; Metallurgy | 0 | Active |
| US6160108A | Platelet activation protein | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.